(±)-NBI 74330
Chemical Name: N-1-[(3-4(-Ethoxyphenyl)-3,4-dihydro-4-oxopyrido[2,3-d]pyrimidin-2-yl]ethyl]-4-fluoro-N-(3-pyridinylmethyl)-3-(trifluoromethyl)benzeneacetamide
Purity: ≥98%
Biological Activity
(±)-NBI 74330 is a potent and selective CXCR3 antagonist; potently inhibits 125I-CXCL10 binding to CXCR3 (pKi = 8.13). Inhibits calcium mobilization in response to CXCL11 and CXCL10 in RBL cells. Exhibits no significant effect on chemotaxis induced by CXCR4 or CCR7. Displays a five-fold greater affinity for CXCR3 than (±)-AMG 487.This product is racemic.
Technical Data
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Additional Information
- This compound is racemic
Background References
-
Osteoblasts secrete Cxcl9 to regulate angiogenesis in bone
Nat Commun, 2016;7(0):13885. -
Synthesis and structure-activity relationships of 3H-quinazolin-4-ones and 3H-pyrido[2,3-d]pyrimidin-4-ones as CXCR3 receptor antagonists.
Storelli et al.
Arch.Pharm., 2007;340:281 -
Noncompetitive antagonism and inverse agonism as mechanism of action of nonpeptidergic antagonists at primate and rodent CXCR3 chemokine receptors.
Verzijl et al.
J.Pharmacol.Exp.Ther., 2008;325:544 -
Pharmacological characterization of CXC chemokine receptor 3 ligands and a small molecule antagonist.
Heise et al.
J.Pharmacol.Exp.Ther., 2005;313:1263 -
The atypical chemokine receptor 3 interacts with Connexin 43 inhibiting astrocytic gap junctional intercellular communication
A Fumagalli, J Heuninck, A Pizzoccaro, E Moutin, J Koenen, M Séveno, T Durroux, MP Junier, G Schlecht-L, F Bachelerie, D Schütz, R Stumm, MJ Smit, NC Guérineau, S Chaumont-D, P Marin
Nat Commun, 2020;11(1):4855.
Product Datasheets
Reconstitution Calculator
Molarity Calculator
Citation for (±)-NBI 74330
The citations listed below are publications that use Tocris products. Selected citations for (±)-NBI 74330 include:
1 Citation: Showing 1 - 1
-
Pharmacological blockade of CXCR3 by (�)-NBI-74330 reduces neuropathic pain and enhances opioid effectiveness - Evidence from in vivo and in vitro studies.
Authors: Piotrowska Et al.
Biochim.Biophys.Acta 2018;1864:3418
FAQs
No product specific FAQs exist for this product, however you may
View all Small Molecule FAQsReviews for (±)-NBI 74330
There are currently no reviews for this product. Be the first to review (±)-NBI 74330 and earn rewards!
Have you used (±)-NBI 74330?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image